Inomagen Therapeutics
Sponsors visas
Facts
as of Nov 15, 2026Inomagen Therapeutics. Developing a non-viral disease-modifying gene therapy to improve the treatment of atrial fibrillation.
- Legal name
- Inomagen Therapeutics, Inc.
- Headquarters
- Chicago, United States
- Register numbers
- NAME inomagen therapeutics inc
- Official records
- SEC CIK 1626370
- Website
- inomagen.com
These are the key facts about Inomagen Therapeutics on Alion as of Nov 15, 2026. Inomagen Therapeutics is headquartered in Chicago, United States. It has raised $340k in 2 funding rounds. The latest round is Venture - Series Unknown of $140k, announced in 2025.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Inomagen Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Visa
Full chapter →Named in the work visa registers of United States.
0H-1B filings in 12 months
0Open roles in United States
In the register as Inomagen Therapeutics, Inc, Chicago, IL
Alert me
US Department of Labor · latest filing May 20, 2025
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Chicago United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$540kTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Jun 5, 2025
Raised a round Venture round $140k · SEC Form D
Mar 29, 2024
Raised a round Venture round $200k · SEC Form D
Each milestone is dated by its source: registers, filings, the press